SynthesisEndocrine2026
Growth hormone deficiency: craniofacial characteristics and changes after growth hormone therapy - a systematic review.
Synthesis in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGrowth hormone deficiency (GHD) is among the most common pituitary hormone disorders in children, causing impaired growth in children and may also affect craniofacial and dental development. Growth hormone therapy (GHT) is the main course of treatment. Despite the high prevalence of GHD, the craniofacial phenotype associated with GHD and the changes observed during therapy have been only partially reviewed in the current literature. PURPOSE: This systematic review aimed to compile evidence from January 2000 to April 2026 regarding the craniofacial features of children and adolescents with non-syndromic GHD, as well as the craniofacial changes observed during GHT.
methodsPubMed, Google Scholar and Scopus were searched for studies published from 2000 to April 2026 that assessed craniofacial or dental changes in non-syndromic GHD patients undergoing GHT. Two reviewers screened the studies and assessed risk of bias using the AXIS tool and the Newcastle-Ottawa Scale. Owing to methodological and clinical heterogeneity, a meta-analysis was not performed.
resultsA total of 621 records were identified; after removing duplicates and applying screening criteria, 10 studies were included. Baseline data generally showed that children with GHD had smaller cranial base and jaw dimensions, retrognathic maxillary and mandibular positions, increased facial convexity, and delayed dental development or eruption compared to healthy peers. Studies on GHT mostly reported craniofacial growth approaching reference values, especially in the maxilla, mandibular ramus, and facial height. Nonetheless, the evidence was limited by small sample sizes, diverse outcome measures, mixed control groups, and generally moderate risk of bias.
conclusionAvailable observational evidence indicates that non-syndromic GHD is associated with a characteristic pattern of craniofacial underdevelopment and delayed dentofacial maturation, whereas GHT may partially normalize several craniofacial parameters. These findings should be interpreted with caution because all included studies were observational and clinically diverse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.